Key Insights

Highlights

Treatment Research

1 treatments under study, led by Orcaq

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05322850Phase 1/2Recruiting

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Showing all 1 trials

Research Network

Common Treatments

  • Orcaq1

Active Sponsors

  • Orca Biosystems, Inc.1
  • University of Florida1

Top Investigators

Related Conditions

  • Mixed Phenotype Acute Leukemia1
  • Chronic Myeloid Leukemia Accelerated Phase1
  • Acute Myeloid Leukemia1
  • Acute Undifferentiated Leukemia1
  • Chronic Myeloid Leukemia In Myeloid Blast Crisis1

Activity Timeline